The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patients: a literature review

Imatinib and nilotinib are first-line treatments for chronic myeloid leukemia (CML) patients, which act specifically against target cells. However, these drugs may cause side effects, such as electrolyte disturbances. This literature review aimed to provide a comparison of the effects of imatinib an...

Descripción completa

Detalles Bibliográficos
Autores principales: Prenggono, Muhammad Darwin, Yasmina, Alfi, Ariyah, Misna, Wanahari, Tenri Ashari, Hasrianti, Nuvita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649642/
https://www.ncbi.nlm.nih.gov/pubmed/34976304
http://dx.doi.org/10.4081/oncol.2021.547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649642/
https://www.ncbi.nlm.nih.gov/pubmed/34976304
http://dx.doi.org/10.4081/oncol.2021.547

Ejemplares similares